⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMRX News
Amneal Pharmaceuticals, Inc. Class A Common Stock
Biosimilars Market worth $70.79 billion by 2036 - Exclusive Report by MarketsandMarkets™
prnewswire.com
PFE
AMGN
AMRX
Global Peptide Synthesis Market Outlook Report 2026-2035 | Set to Reach USD 7 Billion by 2035, Driven by GLP-1 Demand and Manufacturing Capacity Expansion
globenewswire.com
VKTX
AMRX
Zambon gibt EU-Zulassung für Hopledo® zur Behandlung moderater bis schwerer motorischer Fluktuationen bei Erwachsenen mit Parkinson bekannt
businesswire.com
AMRX
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations
businesswire.com
AMRX
Zambon annuncia l’approvazione da parte della Commissione Europea di Hopledo® per pazienti adulti con Malattia di Parkinson e fluttuazioni motorie da moderate a severe
businesswire.com
AMRX
Zambon anuncia a aprovação de Hopledo®, por parte da Comissão Europeia, um medicamento para adultos com doença de Parkinson e flutuações motoras moderadas a graves
businesswire.com
AMRX
Zambon kondigt Europese goedkeuring aan van Hopledo® voor volwassenen met de ziekte van Parkinson en matige tot ernstige motorische fluctuaties
businesswire.com
AMRX
Blood Cancer Therapeutics Market to Reach $125.5 Billion by 2030, Driven by Precision Medicine Advances and Expanding Immunotherapy Pipelines
globenewswire.com
ABBV
AMGN
AZN
BMY
ROG
GILD
GSK
JNJ
LLY
MRK
NVS
SNY
PFE
JAZZ
AMRX
Carboprost Tromethamine Market to Reach USD 2.79 Billion by 2031 as Postpartum Hemorrhage Treatment Demand Rises
globenewswire.com
PFE
RDY
TEVA
AMRX
SUN
GLAD
Global Lenalidomide Market to Reach USD 20.85 Billion by 2031, Advancing at a 5.39% CAGR
globenewswire.com
BMY
TEVA
RDY
CI
NAT
AMRX
SUN
VTRS